I feel quite emotional having listened to @daveback01 summarising 40 years of antiretroviral pharmacology & the history of @pandtuol@LivUni. So much progress to celebrate but also a reminder that people matter more than things. What an inspiration! #AtTheEquatorUG#AntiviralPK
#AntiviralPK challenging and fascinating talk by @aeolagunju on perinatal considerations for long acting medications. Pregnant & breastfeeding women are a major part of society, must not be neglected and we need to harness the very best science to advance knowledge @wellcometrust
🚨 RECRUITMENT NEWS
We're looking for a #DataCurator from a relevant field, for maintenance of open access platforms tracking global development, patent & regulatory status of #LongActing therapeutics & technologies.
Deadline: 2/2/24.
Find out more here
👉https://t.co/LP8Z8r9rso
📢We're hiring!
A data curator @CELTLiverpool for further development & maintenance of open access platforms for tracking global development, patent & regulatory status of long-acting therapeutics & technologies.
Details: https://t.co/Xim6K9uVuO
Check our paper in @VirusesMDPI
on a hamster infection model with #SARSCoV2 subvariants BA.2.86 and EG.5.1 (the latter is the parent of the JN sub-variants) @KU_Leuven @SSI_dk @MDPIOpenAccess
https://t.co/Fo5uPOdGVx
https://t.co/Fo5uPOdGVx
Approximately 75% of people living with #HepatitisC reside in #LMICs with the majority having limited access to life-saving medication.
Find out how the #LONGEVITYProject aims to ease the #HCV burden with #longacting injectable medicines.
👉https://t.co/Scai2brB0p
"It’s important to acknowledge that objectively we are in a better place with regard to the virus than we’ve ever been"
from @today's @NEJM commentary
https://t.co/E08WE0W4Rw
We're recruiting for a Mathematical Modeller in Pharmacokinetics for a Medical Research Council funded project.
✅Research the next generation of newly formulated drugs
✅Progress new approaches to therapy
✅Join a multi-disciplinary team
Job spec here: https://t.co/ZoebVKFOmj
Good news: In the Northeast where the XBB.1.5 variant now accounts for >75% cases, hospital admissions among seniors have mostly started to decline
https://t.co/MOQpgmNWGl
New hit-to-lead grants for drugs against malaria, TB, chagas, and visceral leishmaniasis: https://t.co/3Re0mJdhIi
Compounds must come from a Japanese library, partner with @MedsforMalaria, @DNDi, or @TBAlliance. Grants up to 2 years, Intent to Apply deadline = Feb 10th
This nationwide study suggests that patients with mild covid-19 are at risk for a small number of health outcomes, most of which are resolved within a year from diagnosis https://t.co/yjZEIqddPh
Some #SARSCoV2 mutations that confer resistance to Paxlovid have been deposited @NCBI & @GISAID
https://t.co/bzgje9aYqJ @ScienceTM
"Our findings argue for highly selective use...because extensive, unselective use is expected to rapidly lead to emergence of drug resistance."
Congratulations 👏🏾 to #Uganda 🇺🇬 for declaring the end of the #Ebola outbreak today, less than four months after the confirmation of the first case.
https://t.co/hRFE6QBm6C